NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ: KROS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Read More Details
Finally We wish PressBee provided you with enough information of ( SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keros Therapeutics, Inc. - KROS )
Also on site :
- Sen. Thom Tillis Announces Retirement After Trump Threatens Primary Race
- Marshall says he believes Trump megabill ‘will help shrink the debt’
- Jensen Ackles Makes Rare Comment About 'Supernatural' Fans